Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

BUY
$79.4 - $116.36 $151,415 - $221,898
1,907 Added 57.35%
5,232 $418,000
Q1 2022

May 10, 2022

BUY
$86.42 - $109.81 $287,346 - $365,118
3,325 New
3,325 $350,000
Q2 2021

Aug 13, 2021

SELL
$86.24 - $95.92 $407,828 - $453,605
-4,729 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$71.83 - $95.48 $339,684 - $451,524
4,729 New
4,729 $413,000
Q4 2020

Feb 16, 2021

SELL
$67.0 - $84.39 $242,540 - $305,491
-3,620 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$55.23 - $79.93 $199,932 - $289,346
3,620 New
3,620 $281,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Parametrica Management LTD Portfolio

Follow Parametrica Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Parametrica Management LTD with notifications on news.